Skip to Content

Grant Support

Faculty/Role Funding Agency Title
Capitini, Christian M (PI) DHHS, PHS, National Institutes of Health Inhibiting STAT1 as a Novel Graft-Versus-Host/Graft-Versus-Leukemia Therapy
Capitini, Christian M (PI) Novartis A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients with Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia
Capitini, Christian M (PI) Midwest Athletes Against Childhood Cancer Exploitation of the STAT1-BCL2 Axis to Dissect GVL from GVHD
Capitini, Christian M
Otto, Mario (Young Investigators)
Stand Up 2 Cancer Foundations Immunogenomics to Create New Therapies for High-risk Childhood Cancers
Capitini, Christian M (Mentor) American Society of Hematology Hematology Opportunities for the Next Generation of Research Scientists (Tara Gavcovich)
Capitini, Christian M (PI) Vilas (William F) Trust Estate Vilas Faculty Early Career Investigator Award
Capitini, Christian M (Mentor) St Baldrick’s Foundation Summer fellowship support (Tara Gavcovich)
Capitini, Christian M (PI) American Association of Immunologists Careers in Immunology Fellowship (M. Bouchlaka)
Capitini, Christian M (PI) UW SMPH/ICTR Centennial Scholar
Capitini, Christian M (PI) UWF - University of Wisconsin Foundation MEMS as Protection from GVHD (ICTR pilot)
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia COG Per Case & Specimen Reimbursement
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia CCOP: COG Per Case Reimbursement
DeSantes, Kenneth B (PI) National Marrow Donor Program 11 TREO: A Phase II Study of Treosulfan/Fludarabine/Low Dose Total Body Irradiation as a Preparative Regiment for Children with AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia COG Workload Intensity
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ANBL0532 CTSU PCR
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ADVL1122: A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD - AAML1031
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia PIDTC Per Case Reimbursement
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia A Phase II Study of MLN8237 (IND#102984), a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias (ADVL0921)
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ACNS1021 - PFIZER NO. WS281593-48
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ANHL1131 - Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia AALL1131 - A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC #606869) in the Very High Risk Stratum
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia St. Baldrick's Supplemental Per Case Reimbursement (COG)
DeSantes, Kenneth B (PI) Solving Kids’ Cancer Phase I Trial of Ex-Vivo Expanded Haploidentical NK Cells and Hu14.18-IL2 for Children with Relapsed/Refractory Neuroblastoma
DeSantes, Kenneth B (PI)
Otto, Mario (co-I)
Sondel, Paul M (collaborator)
Midwest Athletes Against Childhood Cancer Alpha/Beta T-Cell Depleted Haploidentical Transplantation with Post-Transplant Zoledronic Acid to Treat Recurrent or Refractory Pediatric Malignancies
DeSantes, Kenneth B (PI)
Sondel, Paul M (co-I)
Midwest Athletes Against Childhood Cancer Support for Research Data Management
DeSantes, Kenneth B (co-I) with
Hei, Derek (PI)
National Institutes of Health PACT
Otto, Mario (PI) Hyundai Hope on Wheels A Novel Phospholipid Ether Analog to Combine Targeted Molecular Radiotherapy and Immunotherapy in Pediatric Solid Tumors
Otto, Mario (PI) NIH-NCI “A Cancer-targeted Phospholipid Ether Analog for Molecular Radiotherapy of Pediatric Solid Tumors
Otto, Mario (PI) Midwest Athletes Against Childhood Cancer Effect of Zoledronate on Engraftment and t-cell Development After TCR alpha-ß/CD19-depleted Hematopoietic Stem Cell Transplantation
Otto, Mario (PI) Midwest Athletes Against Childhood Cancer A Tumor-selective Alkyl Phospholipid Analog for the Treatment of Pediatric Solid Malignancies
Otto, Mario (co-PI) Midwest Athletes Against Childhood Cancer Alpha/beta t-cell Depleted Haploidentical Transplantation with Post-transplant Zoledronic Acid to Treat Recurrent or Refractory Pediatric Malignancies
Puccetti, Diane M (PI) Midwest Athletes Against Childhood Cancer Psychosocial Aspects of Ending Treatment & Long-Term Survival of Pediatric Cancer Patients: A Joint Proposal
Sondel, Paul M (PI) DHHS, PHS, National Institutes of Health Antitumor Mechanisms of alpha-CD40/CpG-activated Macrophages
Sondel, Paul M (PI) St Jude Medical A Phase I Trial of the Humanized Anti-GD2 Antibody (HU14.18K322A) in Children and Adolescents with Neuroblastoma or Melanoma
Sondel, Paul M (PI) St Jude Medical A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (Hu14.18K322A) with and without Natural Killer Cells to chemotherapy in Children and Adolescents with Recurrent / Refractory Neuroblastoma
Sondel, Paul M (PI)
Desantes, Kenneth B (co-I)
Capitini, Christian M and
Otto, Mario (young investigators)
Children's Hospital of Philadelphia Immunogenomics to Create New Therapies for High-Risk Childhood Cancers
Sondel, Paul M (PI) Hyundai Hope On Wheels Novel Modification of Anti-GD2 Immunocytokine Design and Delivery Regimens to Augment T-cell Involvement and Boost Anti-Neuroblastoma Efficacy
Sondel, Paul M (PI) Midwest Athletes Against Childhood Cancer Neuroblastoma Tumor Escape Variants Modulate MHC Class I Expression in Response to NK- to T cell-Mediated Immunotherapy
Sondel, Paul M (PI) Hughes (Howard) Medical Institute Description and Characterization of Endogenous Antibodies Found in Some Cancer Patients That are Capable of Recognizing Various Monoclonal Antibodies used in Cancer Immunotherapy (J. Goldberg)
Sondel, Paul M (PI) American Society For Radiation Oncology Engaging Antibody-Dependent Cell-Mediated Cytotoxicity to Augment the Synergy of Radiation and T-cell Checkpoint Inhibition (Z. Morris)
Sondel, Paul M (PI) DHHS, PHS, National Institutes of Health The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy
Sondel, Paul M (PI) DHHS, PHS, National Institutes of Health Clinical Development of HU 14.18-IL2 Targeted Therapy
Sondel, Paul M (PI) Children's Hospital of Philadelphia COG Sci. Leadership 2013-14
Sondel, Paul M (PI) UW SMPH/ICTR In-Depth Delineation of FC1R11 (ICTR Pilot)
Sondel, Paul M
(chair, scientific review committee) with
Drezner, Marc (PI)
NIH-NCATS UW-ICTR

Last updated: 01/04/2016
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2016 The Board of Regents of the University of Wisconsin System